Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Employee Offers Personal Account of NIH-Supported Clinical Research

A closer look at eyeGENE
July 22, 2022
Genetics Retinitis Pigmentosa
Clinical Research
eyeGENE
Dr. David Kosub

Dr. David Kosub shares his first-hand experience as a participant in an NIH clinical study.

To truly understand someone’s experience, put yourself in their shoes. No doubt, you have heard this adage and it is certainly the case for the many people who participate in clinical research. Many of us who work at NIH regularly say how invaluable clinical study participants are to improving public health, but have you tried on their shoes yet?

I was first exposed to clinical research as a graduate student. Although financial compensation did provide some motivation (I was a poorly paid grad student after all), the promise of turning clinical research discoveries into public health benefit was the principal driver for my continued participation. As interesting and educational as these opportunities were, they did not study genetic retinal diseases that cause progressive vision loss—something close to home for me.

So, I searched “retinitis pigmentosa” in ClinicalTrials.gov, and inquired about a study. I soon received a response, which to my shock actually came from the then-director of the National Eye Institute.